Eupraxia Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights

Eupraxia Pharmaceuticals Inc share price today is $7.1, up -6.58%. The stock opened at $7.5 against the previous close of $7.6, with an intraday high of $7.52 and low of $7.06.

Eupraxia Pharmaceuticals Inc Share Price Chart

Eupraxia Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
us-stock

Eupraxia Pharmaceuticals Inc Share Price Performance

$7.1 -0.0658(-6.58%) EPRX at 23 Mar 2026 12:54 PM Biotechnology
Lowest Today 7.06
Highest Today 7.52
Today’s Open 7.5
Prev. Close 7.6
52 Week High 9.32
52 Week Low 2.68
Day’s Range: Low 7.06 High 7.52
52-Week Range: Low 2.68 High 9.32
1 day return -
1 Week return -4.17
1 month return -12.86
3 month return +1.57
6 month return +8.21
1 year return +94.79
3 year return -
5 year return -
10 year return -

Eupraxia Pharmaceuticals Inc Institutional Holdings

Eupraxia Pharmaceuticals Inc Market Status

Eupraxia Pharmaceuticals Inc Fundamentals

Market Cap 424.41 M

PB Ratio 7.9414

PE Ratio 0.0

Enterprise Value 364.68 M

Total Assets 117.99 M

Volume 258256

Eupraxia Pharmaceuticals Inc Company Financials

Annual Revenue FY23:0 0.0M

Annual Profit FY23:null 0.0M

Annual Net worth FY23:-28220796 -28.2M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-86883 -0.1M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:-57508 -0.1M

Quarterly Net worth Q3/2025:-8851524 -8.9M, Q2/2025:-11908886 -11.9M, Q1/2025:-9630697 -9.6M, Q3/2024:-5943325 -5.9M, Q2/2024:-6007216 -6.0M

About Eupraxia Pharmaceuticals Inc & investment objective

Company Information Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company's product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of gastrointestinal tract, such as eosinophilic esophagitis. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.

Organisation Biotechnology

Employees 49

Industry Biotechnology

CEO Dr. James A. Helliwell FRCPC, M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Eupraxia Pharmaceuticals Inc FAQs

What is the share price of Eupraxia Pharmaceuticals Inc today?

The current share price of Eupraxia Pharmaceuticals Inc is $7.1.

Can I buy Eupraxia Pharmaceuticals Inc shares in India?

Yes, Indian investors can buy Eupraxia Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Eupraxia Pharmaceuticals Inc shares in India?

You can easily invest in Eupraxia Pharmaceuticals Inc shares from India by:

Can I buy fractional shares of Eupraxia Pharmaceuticals Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Eupraxia Pharmaceuticals Inc?

Eupraxia Pharmaceuticals Inc has a market cap of $424.41 M.

In which sector does Eupraxia Pharmaceuticals Inc belong?

Eupraxia Pharmaceuticals Inc operates in the Biotechnology sector.

What documents are required to invest in Eupraxia Pharmaceuticals Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Eupraxia Pharmaceuticals Inc?

The PE ratio of Eupraxia Pharmaceuticals Inc is N/A and the PB ratio is 7.94.